Literature DB >> 26343175

Anesthetic management of placenta accreta in a low-resource setting: a case series.

L A Muñoz1, G J Mendoza2, M Gomez3, L E Reyes2, J J Arevalo2.   

Abstract

BACKGROUND: Current recommendations for the anesthetic management of placenta accreta support a conservative approach with neuraxial anesthesia and uterine artery embolization. These are based on case series from experienced centers in developed countries. The aim of this study was to describe the anesthetic management of placenta accreta in a low-resource setting.
METHODS: A retrospective case note review was performed. From 1 August 2006 to 31 July 2011 placentas from cases of suspected placenta accreta were reassessed histologically to confirm the diagnosis. Patient charts were reviewed and information on anesthetic technique, monitoring, blood transfusion, maternal and fetal outcomes was extracted.
RESULTS: Thirty-nine cases were identified. Mean (± SD) maternal age was 33 ± 5.4 years. Hysterectomy was performed at the time of cesarean section in all cases. Thirty-four patients received neuraxial anesthesia, of whom 15 required conversion to general anesthesia. Invasive blood pressure monitoring was used in all patients and a central venous catheter was inserted in 33 cases. Complications associated with monitoring occurred in five patients. Median [IQR] blood loss was 2000 [1100-2700] mL and the median [IQR] number of units of red blood cell transfused was 2 [0-6]. Vasoactive medication was used in 14 patients and 15 patients were transferred to the intensive care unit postoperatively. No maternal or newborn deaths occurred.
CONCLUSION: A multidisciplinary approach can prove valuable when placenta accreta is suspected before delivery. In low-resource settings, lack of interventional radiology services and prenatal diagnostic capability may have an impact on anesthetic management in patients with placenta accreta. However, other than greater blood loss, our study demonstrated that good maternal and neonatal outcomes are possible in spite of limited resources.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anesthetic management; Hysterectomy; Low-resource setting; Placenta accreta

Mesh:

Year:  2015        PMID: 26343175     DOI: 10.1016/j.ijoa.2015.05.005

Source DB:  PubMed          Journal:  Int J Obstet Anesth        ISSN: 0959-289X            Impact factor:   2.603


  4 in total

1.  Placenta accreta spectrum anaesthetic management with neuraxial technique can be facilitated by multidisciplinary groups.

Authors:  Leidy Johanna Lopez-Erazo; Beatriz Sánchez; Luisa Femanda Blanco; Albaro Jose Nieto-Calvache
Journal:  Indian J Anaesth       Date:  2021-02-10

2.  Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial.

Authors:  Qinjun Chu; Dan Shen; Long He; Hongwei Wang; Xianlan Zhao; Zhimin Chen; Yanli Wang; Wei Zhang
Journal:  Trials       Date:  2017-05-26       Impact factor: 2.279

3.  Clinical outcomes and anesthetic management of pregnancies with placenta previa and suspicion for placenta accreta undergoing intraoperative abdominal aortic balloon occlusion during cesarean section.

Authors:  Peng Li; Xia Liu; Xiangkui Li; Xinchuan Wei; Juan Liao
Journal:  BMC Anesthesiol       Date:  2020-05-30       Impact factor: 2.217

4.  Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders.

Authors:  Yalda Afshar; Jiantong Dong; Pan Zhao; Lei Li; Shan Wang; Ryan Y Zhang; Ceng Zhang; Ophelia Yin; Christina S Han; Brett D Einerson; Tania L Gonzalez; Huirong Zhang; Anqi Zhou; Zhuo Yang; Shih-Jie Chou; Na Sun; Ju Cheng; Henan Zhu; Jing Wang; Tiffany X Zhang; Yi-Te Lee; Jasmine J Wang; Pai-Chi Teng; Peng Yang; Dongping Qi; Meiping Zhao; Myung-Shin Sim; Ruilian Zhe; Jeffrey D Goldstein; John Williams; Xietong Wang; Qingying Zhang; Lawrence D Platt; Chang Zou; Margareta D Pisarska; Hsian-Rong Tseng; Yazhen Zhu
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.